5-Bromoquinazolin-6-Ylthiourea: Heavy Metal Limits for Ophthalmic APIs
Heavy Metal Trace Limits in 5-Bromoquinazolin-6-ylthiourea: Standard vs. Ultra-Low Metal Grades for Ophthalmic Precursors
When sourcing 5-Bromoquinazolin-6-ylthiourea (CAS 842138-74-3) as a Brimonidine precursor, procurement managers must scrutinize heavy metal profiles beyond standard pharmacopoeial thresholds. This thiourea derivative, also cataloged as N-(5-bromo-6-quinoxalinyl)thiourea or 5-Bromoquinoxalin-6-ylthiourea, serves as a critical intermediate in synthesizing Brimonidine EP Impurity D. For ophthalmic applications, even trace metals at parts-per-billion levels can catalyze oxidative degradation in final formulations, compromising solution clarity and patient safety. Standard industrial grades often carry residual palladium (up to 50 ppm) and copper (up to 20 ppm) from catalytic coupling steps, but ultra-low metal grades tailored for sterile eye-drop lines demand Pd ≤ 1 ppm, Cu ≤ 2 ppm, and cadmium below detection limits. Our high-purity 5-Bromoquinazolin-6-ylthiourea is manufactured under controlled chelating washes to achieve these stringent limits, ensuring a drop-in replacement for original sources without compromising yield in imidazoline cyclization. The table below compares typical heavy metal specifications across three purity grades relevant to ophthalmic synthesis.
| Parameter | Standard Technical Grade | High Purity (API Intermediate) | Ultra-Low Metal (Ophthalmic) |
|---|---|---|---|
| Assay (HPLC) | ≥ 97.0% | ≥ 99.0% | ≥ 99.5% |
| Palladium (Pd) | ≤ 50 ppm | ≤ 5 ppm | ≤ 1 ppm |
| Copper (Cu) | ≤ 20 ppm | ≤ 5 ppm | ≤ 2 ppm |
| Cadmium (Cd) | ≤ 10 ppm | ≤ 1 ppm | ≤ 0.1 ppm |
| Lead (Pb) | ≤ 10 ppm | ≤ 2 ppm | ≤ 0.5 ppm |
| Mercury (Hg) | ≤ 5 ppm | ≤ 1 ppm | ≤ 0.1 ppm |
| Loss on Drying | ≤ 0.5% | ≤ 0.3% | ≤ 0.2% |
| Appearance | Off-white to pale yellow powder | White to off-white powder | White crystalline powder |
Note: Actual values may vary; please refer to the batch-specific COA. The ultra-low metal grade is particularly critical when the subsequent Brimonidine synthesis route involves aqueous buffers where metal ions can form colored complexes or accelerate API degradation.
Residual Palladium and Copper: Catalytic Origins and Their Role in Oxidative Browning of Aqueous Eye-Drop Buffers
In the manufacturing process of 5-Bromoquinazolin-6-ylthiourea, palladium-catalyzed cross-couplings (e.g., Buchwald-Hartwig or Suzuki reactions) are common for constructing the quinazoline core. Residual palladium, if not adequately scavenged, can persist as Pd(0) or Pd(II) species. Similarly, copper residues from Ullmann-type couplings or Sandmeyer reactions may remain. In ophthalmic formulations, these metals act as Fenton-like catalysts, generating reactive oxygen species that oxidize brimonidine and cause yellow-to-brown discoloration over time. Even at sub-ppm levels, copper ions can complex with thiourea moieties, forming colored species that fail visual inspection. Our field experience shows that a non-standard parameter—the redox potential of the final intermediate—can predict long-term stability: batches with Pd < 1 ppm and Cu < 2 ppm consistently yield aqueous solutions with less than 0.1 AU color change after 12-month accelerated aging. This edge-case behavior is often overlooked in standard COAs but is vital for quality assurance in sterile manufacturing lines. For procurement managers evaluating bulk price versus purity, investing in ultra-low metal grades reduces downstream purification costs and batch rejection risks. As discussed in our related article on drop-in replacement strategies for Sigma's 5-Bromo-6-Thioureidoquinoxaline, matching or exceeding original purity profiles is essential for seamless integration into existing synthetic protocols.
Chelating Wash Protocols: Ensuring Solution Transparency and Stability in Brimonidine Impurity D Synthesis
To achieve the ultra-low metal specifications required for ophthalmic precursors, advanced chelating wash protocols are employed during the final purification of 5-Bromoquinazolin-6-ylthiourea. These protocols typically involve aqueous EDTA or NTA washes at controlled pH to selectively complex and remove divalent and trivalent metal ions without hydrolyzing the thiourea group. However, overly aggressive chelation can reduce overall yield by 2–5% due to product solubility losses. Our optimized process balances metal removal efficiency with yield retention, delivering a product that meets the stringent heavy metal limits while maintaining >99% assay. A critical non-standard parameter we monitor is the residual chelator content, as even trace EDTA can interfere with subsequent imidazoline cyclization by sequestering catalytic metal ions. Batch-specific COAs include a proprietary "chelator-free" test to ensure no carryover. This attention to detail is especially important when the 5-Bromoquinoxalin-6-ylthiourea is used as a Brimonidine precursor in multi-step syntheses where metal-sensitive steps follow. For logistics considerations, our bulk shipping guidelines for winter conditions detail how moisture control during transport preserves the integrity of these low-metal grades, preventing hydrolysis that could release trace metals from packaging materials.
Batch-Specific COA Parameters: Interpreting Heavy Metal Profiles and Non-Standard Purity Indicators for Bulk Procurement
When reviewing a certificate of analysis for 5-Bromoquinazolin-6-ylthiourea, beyond the standard assay and heavy metal limits, several non-standard parameters provide deeper insight into suitability for ophthalmic applications. These include:
- Residual Solvents: Class 1 and 2 solvents must be below ICH limits, but even Class 3 solvents like acetone or ethyl acetate can affect crystallization behavior in downstream steps.
- Chloride Content: Ionic chloride from quench steps can corrode stainless steel reactors and catalyze decomposition; our ultra-low metal grade targets < 50 ppm.
- Color (APHA): A 10% solution in DMF should have APHA < 20 for the highest grade, indicating absence of colored metal complexes or oxidation byproducts.
- Crystallization Behavior: At sub-zero temperatures during winter shipping, this compound can exhibit viscosity shifts that affect powder flow; our packaging in moisture-barrier drums with desiccant mitigates clumping. Please refer to the batch-specific COA for exact data.
Procurement managers should also request a heavy metal profile by ICP-MS, not just the compendial heavy metals limit test, to quantify individual metals. This data is crucial for risk assessment in sterile manufacturing. Our custom synthesis team can tailor metal specifications to your process requirements, offering a true global manufacturer partnership with fast delivery from multiple stocking points.
Frequently Asked Questions
Which specific metal impurities most impact final solution clarity in brimonidine formulations?
Copper and iron are the most detrimental. Copper ions form colored complexes with thiourea derivatives, while iron catalyzes oxidative degradation. Palladium, though less chromophoric, can generate colloidal particles that scatter light. For sterile ophthalmic solutions, Cu < 2 ppm and Fe < 1 ppm are recommended.
How do chelating washes affect overall yield of 5-Bromoquinazolin-6-ylthiourea?
Typical chelating washes with EDTA at pH 6–7 can reduce yield by 2–5% due to slight solubility of the product in aqueous phase. Optimized protocols using minimal volumes and controlled contact times limit yield loss to < 2% while achieving > 95% metal removal efficiency.
What assay grades justify the premium cost for sterile ophthalmic lines?
For ophthalmic API intermediates, an assay of ≥ 99.5% with individual heavy metals below 2 ppm is the benchmark. The premium cost is justified by reduced downstream purification, lower batch failure rates, and compliance with ICH Q3D guidelines for elemental impurities in final drug products.
Can 5-Bromoquinazolin-6-ylthiourea be shipped in winter without degradation?
Yes, with proper moisture control. The compound is stable at low temperatures, but condensation upon warming can cause hydrolysis. We ship in heat-sealed, moisture-barrier bags inside 210L drums or IBCs with desiccant, ensuring integrity even during temperature fluctuations.
Is a drop-in replacement for Sigma's product truly equivalent?
Our product is manufactured to match or exceed the purity profile of the original source, with identical CAS and molecular structure. We provide comparative COAs and offer sample validation to confirm seamless substitution in your process.
Sourcing and Technical Support
Selecting the right grade of 5-Bromoquinazolin-6-ylthiourea for ophthalmic precursor synthesis demands a thorough understanding of heavy metal impacts on final product quality. NINGBO INNO PHARMCHEM CO.,LTD. offers a range of purities backed by comprehensive analytical data and logistics expertise to ensure your supply chain remains robust. Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.